Clinical Trial: Impact of AI-Based Breath Ammonia Kidney Function Results on Clinical Pharmacist Medication Recommendations

U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07888855) titled 'Impact of AI-Based Breath Ammonia Kidney Function Results on Clinical Pharmacist Medication Recommendations' on Sept. 30.

Brief Summary: This retrospective study evaluates whether providing clinicians with artificial intelligence (AI)-based kidney function results from a breath ammonia test can improve the quality of medication recommendations made by clinical pharmacists. Using historical inpatient cases from Shanghai Pudong Hospital, each case was evaluated under two information conditions: one with standard clinical information only, and one with the additional AI-based breath test kidney function results. Independent experts bli...